FDA Updates

Do not use OTC cough and cold products among infants and children under two years of age

Republicans are more likely to used vitamin supplement than Democrats

Manufacturers are unleashing a slew of cough and cold over the counter items.

What OTCs do R.Ph.s recommend for cough & cold season?

Consultant pharmacists applaud CMS' guidelines on nursing home surveyors one year after State Operations Manual guidelines become effective.

Coverage of branded drugs, new indications, new formulations, new dosages, along with OTCs.

Drug Topics conducted an exclusive OTC survey for cough, cold and flu products.

FDA is considering how to deal with the phaseout of chlorofluorocarbons from inhalers, which is only a year away.

SAMHSA: 3.1 million young adults have abused OTC cough medicine in their lifetime.

Drug Topics' poll finds pharmacists against Mevacor going OTC.

FDA issues warning on supplements marketed for ED, sexual enhancement

Legislation introduced to restrict access to DHEA

FDA's final rule mandates warning for nonoxynol 9 OTC contraceptives

CHPA supports FDA's recommendations on phenylephrine

Natural Products Association responds to MLB's Mitchell Report

CHPA responds to NIDA's cough medicine abuse monitoring survey

FDA advisory panel rejects Merck's bid for OTC Mevacor

Drug Topics poll: R.Ph.s favor BTC class of drugs

CRN responds to Informed-Choice report calling for transparency in testing dietary supplements

The FDA has approved Ixabepilone (Ixempra) as a monotherapy and in combination with capecitabine (Xeloda) for patients with metastic or locally advanced breast cancer.

The new products include branded drugs, new formulations, new indications, and new dosing, along with OTCs and home health and beauty items.

Pharmacists' organizations were out in force at a recent FDA hearing on the possibility of creating a third category of drugs that would be placed "behind-the-counter" and pharmacist-assisted.

Rxs for Xenical down since OTC Alli released

Sens. John Kerry, Diane Feinstein, and Barbara Boxer urge the FDA to test lipstick for lead

ASHP believes Mevacor is not safe to go over the counter but might be appropriate for behind the counter.

Sens. John Kerry, Diane Feinstein, and Barbara Boxer urge the FDA to test lipstick for lead

Study finds consumers approve of behind-the-counter drugs

FDA extends comment period for proposed sunscreen rule